Project Details
Description
A Randomized, Phase 2, Open-Label Study Evaluating DN24-02 As Adjuvant Therapy In Subjects with High Risk HER2+ Urothelial Carcinoma
| Status | Finished |
|---|---|
| Effective start/end date | 3/3/11 → 12/31/20 |
Funding
- DENDREON CORPORATION
A Randomize, Phase 2, Open-Label Study Evaluating
- Konety, Badrinath R (PI)
Project: Research project